Oropouche virus shedding and immune response study
Part of Infections clinical trials.
This study monitors how long the Oropouche virus stays in the body and how the immune system responds after a positive diagnosis. It may help us better understand the course of the infection and improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have tested positive for Oropouche virus using a PCR test
- You are 18 years old or older
- You agree to take part in the study and allow the use of your data and leftover samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a blood test to look at how your immune system fights certain viruses spread by insects (like mosquitoes). Your participation could help doctors better understand and diagnose these infections.
This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
Hear when a new Oropouche Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.